<!doctype html>
<html class="no-js" lang="">
<head>
  <meta charset="utf-8">
  <meta name="description" content="">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <title>OncoKB Card</title>

  <link rel="apple-touch-icon" href="apple-touch-icon.png">
  <!-- Place favicon.ico in the root directory -->

  <!-- build:css styles/vendor.css -->
  <!-- bower:css -->
  <!-- endbower -->
  <!-- endbuild -->

  <!-- build:css styles/main.css -->
  <link rel="stylesheet" href="styles/main.css">
  <!-- endbuild -->
  <!-- build:js scripts/vendor/modernizr.js -->
  <script src="/bower_components/modernizr/modernizr.js"></script>
  <!-- endbuild -->
</head>
<body>
<!--[if lt IE 10]>
<p class="browserupgrade">You are using an <strong>outdated</strong> browser. Please <a href="http://browsehappy.com/">upgrade your browser</a> to improve your experience.</p>
<![endif]-->
<div class="container">
  <div class="oncokb-card z-depth-2">
    <div>
      <div class="item">
        <div class="col s12 tip-header">
          BRAF V600E in Melanoma
        </div>
        <div class="col s12">
          <ul class="tabs" tabs="">
            <li class="tab col s6">
              <div class="oncogenic" href="#oncogenic">
                <span class="title">clinical implications</span>
                <span class="content">Oncogenic <i class="fa fa-book"></i></span>
              </div>
            </li>
            <li class="tab col s6">
              <div class="mutation-effect">
              <span class="title">Biological Effect</span>
              <span class="content">Likely Switch-of-function <i class="fa fa-book"></i></span></div>
            </li>
            <div class="indicator"></div>
          </ul>
        </div>
        <div id="oncogenic" class="col s12 tabsContent" style="display: block;margin: 10px 10px 0 10px;">
          BRAF encodes an intracellular kinase and component of the pro-oncogenic MAP-kinase signaling pathway. Mutations
          of BRAF are found in various cancers, including melanoma and lung cancer. The BRAF V600E mutation is known to be
          oncogenic.
        </div>
        <div id="mutation-effect" class="col s12 tabsContent" style="display: none;margin: 10px 10px 0 10px;">
          There is level 1 evidence that V600E or V600K mutations in BRAF is associated with response to FDA-approved
          combination of RAF-inhibitor dabrafenib and trametinib in melanoma (PMID: 25287827, 25399551, 25265492), as well
          as dabrafenib monotherapy in non-small cell lung cancer (Planchard, D et al. J Clin. Oncol. abstract 8009;
          2013).
        </div>
      </div>

      <div class="item">
        <table class="bordered table">
          <thead>
          <tr>
            <th>Level</th>
            <th>Drug(s)</th>
            <th>Level-associated<br/>cancer type(s)</th>
            <th>Citation(s)</th>
          </tr>
          </thead>
          <tbody>
          <tr>
            <td><i class="level-icon level-1"></i></td>
            <td>Dabrafenib</td>
            <td>Melanoma</td>
            <td><i class="fa fa-book"></i></td>
          </tr>
          <tr>
            <td><i class="level-icon level-2A"></i></td>
            <td>Trametinib</td>
            <td>Melanoma</td>
            <td></td>
          </tr>
          <tr>
            <td><i class="level-icon level-2B"></i></td>
            <td>Trametinib + Dabrafenib</td>
            <td>Melanoma</td>
            <td></td>
          </tr>
          <tr>
            <td><i class="level-icon level-3A"></i></td>
            <td>Vemurafenib</td>
            <td>Melanoma</td>
            <td></td>
          </tr>
          <tr>
            <td><i class="level-icon level-3B"></i></td>
            <td>Vemurafenib+Cobimetinib</td>
            <td>Melanoma</td>
            <td><i class="fa fa-book"></i></td>
          </tr>
          </tbody>
        </table>
      </div>
      <div class="item">
        <p style="
    padding: 0 10px;
"><i style="color: grey">The information above is intended for research purposes only and should not be used as a substitute for professional
          diagnosis and treatment.</i></p>
      </div>
      <div class="item-list" style="
    /* padding: 0 10px; */
    padding-top: 10px;
">
        <ul class="collapsible" data-collapsible="accordion">
          <li class="">
            <div class="collapsible-header">Levels<span class="secondary-content"><i
              style="color: orange; margin-right: 0;"
              class="glyphicon glyphicon-chevron-down"></i></span>
            </div>
            <div class="collapsible-body levels" style="display: none;">
              <ul>
                <li><b>Level 1:</b> FDA-approved biomarjer and drug in this indication.</li>
                <li><b>Level 2A:</b> Standard-of-care biomarker and drug in this indication but not FDA-approved.</li>
                <li><b>Level 2B:</b> FDA-approved biomarker and drug in another indication, but not FDA or NCCN
                  compendium-listed for this indication.
                </li>
                <li><b>Level 3A:</b> Clinical evidence links biomarker to drug response in this indication but neither
                  biomarker or drug are FDA-approved or NCCN compendium-listed.
                </li>
                <li><b>Level 3B:</b> Clinical evidence links biomarker to drug response in another indication but neither
                  biomarker or drug are FDA-approved or NCCN compendium-listed.
                </li>
              </ul>
            </div>
          </li>
          <li class="">
            <div class="collapsible-header">Powered by OncoKB(Beta)<span class="secondary-content"><i
              style="color: orange; margin-right: 0;" class="glyphicon glyphicon-chevron-down"></i></span></div>
            <div class="collapsible-body" style="display: none;"><p>OncoKB is under development. To report errors or
              missing annotation about this variant, please send us feedback. For general feedback, please send an email
              to oncokb@cbio.mskcc.org</p></div>
          </li>
        </ul>
      </div>
      <div class="item footer">
        <img src="images/oncokb.png" class="oncokb-logo">
        <span class="pull-right feedback"><button class="btn btn-default btn-xs"><i>Feedback</i></button></span></div>
    </div>
  </div>

</div>

<!-- build:js scripts/vendor.js -->
<!-- bower:js -->
<script src="/bower_components/jquery/dist/jquery.js"></script>
<!-- endbower -->
<!-- endbuild -->

<!-- build:js scripts/main.js -->
<script src="scripts/vendor/jquery.easing.1.3.js"></script>
<script src="scripts/vendor/collapsible.js"></script>
<script src="scripts/vendor/tabs.js"></script>
<script src="scripts/main.js"></script>
<!-- endbuild -->
</body>
</html>
